Related Experiment Video
Updated: May 2, 2026

The CYP2D6 Animal Model: How to Induce Autoimmune Hepatitis in Mice
Published on: February 3, 2012
Natural history of vertically acquired HCV infection and associated autoimmune phenomena
Silvia Garazzino1, Carmelina Calitri, Antonella Versace
1Department of Pediatrics, University of Turin, Regina Margherita Children's Hospital, Turin, Italy, silvia.garazzino@unito.it.
Insights
Hepatitis C Virus (HCV) infection acquired vertically may spontaneously clear in 27% of children, particularly with genotype 3. Chronic infections are often asymptomatic but can lead to mild liver fibrosis and autoimmune complications.
Area of Science:
- Pediatric Infectious Diseases
- Hepatology
- Virology
Background:
- The natural history of vertically acquired Hepatitis C Virus (HCV) infection in children is not well-defined.
- Understanding spontaneous viral clearance and associated autoimmune disorders is crucial for managing pediatric HCV.
Purpose of the Study:
- To outline the natural course of vertical HCV infection in untreated children.
- To determine the rate of spontaneous viral clearance and the frequency/features of HCV-related autoimmune disorders.
Main Methods:
- Prospective follow-up of children with vertical HCV infection from one month of age.
- Regular clinical and laboratory assessments, including transient elastography and autoantibody testing.
- Statistical analysis using Prism 5.0.
Main Results:
- 45 children studied (median age 12 years); Genotype 1 was predominant (53.3%).
- Spontaneous viral clearance occurred in 26.7% of patients, associated with genotype 3.
- Hepatomegaly and mild/moderate fibrosis were observed; 53.3% had autoantibodies, and 33.3% had cryoglobulinemia.
Conclusions:
- Vertical HCV infection can resolve spontaneously in up to 27% of children, especially with genotype 3, typically by preschool age.
- Chronic HCV infection in children is usually asymptomatic but may involve hepatomegaly and mild fibrosis.
- Autoantibodies and cryoglobulins are common in vertically infected children, but severe clinical manifestations are rare.
Unlabelled:
The natural history of vertically acquired HCV infection is ill defined. The aim of this study was to outline the natural course of vertical HCV infection in a cohort of untreated children, including rate of spontaneous viral clearance, frequency and features of HCV-related autoimmune disorders. Children with vertical HCV infection were prospectively followed from the first month of life with regular clinical and laboratory assessments. Statistical analysis was performed using Prism 5.0. Forty-five children (median age 12 years, interquartile range 6.9-15.5) were studied. Genotype 1 was predominant (53.3 %). Spontaneous viral clearance was achieved by 12 patients (26.7 %) and associated with genotype 3. Alanine-amino-transferase levels were increased in most children in the first 2 years of life with higher values in those who later cleared the infection. All children were asymptomatic for liver disease. Transient elastography (32 patients) showed mild or moderate fibrosis in nine and two cases, respectively. Non-organ-specific autoantibodies were detected in 24 children (53.3 %) independently of viremia; of these, one developed type-1 diabetes. Cryoglobulinemia was associated with genotype 1 infection and found in 15 subjects (33.3 %): two had low C4 levels and persistent proteinuria.
Conclusions:
Vertically acquired HCV infection may result in spontaneous clearance in up to 27 % of children. Resolution of infection is higher with genotype 3, usually occurs in preschool age and persists over time. Chronic infection is generally asymptomatic, although hepatomegaly and mild fibrosis may develop. Autoantibodies and cryoglobulins are frequent, whereas the associated clinical manifestations are rare.
Related Concept Videos
Hepatitis
Viral Hepatitis I: Introduction
Cytomegalovirus Disease
Autoimmune Disorders
Concept and Mechanism of Autoimmune Diseases
The immune...
Immunodeficiency Diseases
There are three main causes of immunodeficiency...
Cirrhosis II: Pathophysiology

